Cargando…
Research Progress of Heavy Ion Radiotherapy for Non-Small-Cell Lung Cancer
Non-small-cell lung cancer (NSCLC) has a high incidence and poses a serious threat to human health. However, the treatment outcomes of concurrent chemoradiotherapy for non-small-cell lung cancer are still unsatisfactory, especially for high grade lesions. As a new cancer treatment, heavy ion radioth...
Autores principales: | Liang, Siqi, Zhou, Guangming, Hu, Wentao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876478/ https://www.ncbi.nlm.nih.gov/pubmed/35216430 http://dx.doi.org/10.3390/ijms23042316 |
Ejemplares similares
-
Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancer
por: Zhuang, Hongqing, et al.
Publicado: (2014) -
Heavy Ion-Responsive lncRNA EBLN3P Functions in the Radiosensitization of Non-Small Cell Lung Cancer Cells Mediated by TNPO1
por: Tang, Haoyi, et al.
Publicado: (2023) -
Carbon-ion radiotherapy for octogenarians with locally advanced non-small-cell lung cancer
por: Hayashi, Kazuhiko, et al.
Publicado: (2021) -
Value of carbon-ion radiotherapy for early stage non-small cell lung cancer
por: Ruan, Hanguang, et al.
Publicado: (2022) -
Cost‐effectiveness of carbon‐ion radiotherapy versus stereotactic body radiotherapy for non‐small‐cell lung cancer
por: Okazaki, Shohei, et al.
Publicado: (2021)